About
Dan McHugh is a biotech investor and company builder focused on oncology and related enabling technologies. He is Lead Investor and head of the investment team at Yosemite, where he supports companies developing therapeutics, diagnostics, and other oncology tools. He is also a co-founder and board member of Tune Therapeutics and previously served as its interim CEO in 2024.
Areas of interest
oncologybiotechtherapeuticsdiagnosticsepigenetic editinggene therapycell therapyAI for drug discovery